Tesla
TSLA
Apple
AAPL
Meta Platforms
META
Microsoft
MSFT
Petroleo Brasileiro SA Petrobras
PBR
US Stock MarketDetailed Quotes
SLNO Soleno Therapeutics
- 49.1100
- +0.7100+1.47%
Close Mar 21 16:00 ET
- 49.1100
- 0.00000.00%
Post 20:01 ET
2.25BMarket Cap-11.21P/E (TTM)
49.7900High47.2300Low1.38MVolume47.8400Open48.4000Pre Close67.62MTurnover4.73%Turnover RatioLossP/E (Static)45.86MShares60.920052wk High9.19P/B1.44BFloat Cap36.610052wk Low--Dividend TTM29.24MShs Float742.5000Historical High--Div YieldTTM5.29%Amplitude0.8500Historical Low48.9030Avg Price1Lot Size
Soleno Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -177.05%-69.1M | -279.97%-23.99M | -135.72%-14.93M | -217.12%-17.65M | -86.21%-12.53M | -20.01%-24.94M | -22.77%-6.31M | -36.00%-6.33M | -20.48%-5.57M | -5.75%-6.73M |
| Net income from continuing operations | -351.04%-175.85M | -395.59%-55.98M | -605.42%-76.62M | -157.86%-21.85M | -156.08%-21.4M | -62.00%-38.99M | -105.91%-11.3M | -77.12%-10.86M | -26.02%-8.48M | -45.98%-8.36M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | 706.67%182K | -47,100.00%-470K | 32,750.00%653K | ---- | ---- |
| Depreciation and amortization | 1.48%1.99M | 2.86%503K | 2.04%500K | 1.02%494K | 0.00%490K | -0.31%1.96M | 0.20%489K | -0.41%490K | -0.61%489K | -0.41%490K |
| Other non cash items | 21.45%3.69M | -54.40%524K | -9.20%987K | 320.20%1.71M | 19.34%469K | 819.19%3.04M | 318.86%1.15M | 432.84%1.09M | -40.99%406K | 149.81%393K |
| Change In working capital | 105.53%6.02M | 36.96%2.61M | 5,526.53%5.51M | -598.64%-4.04M | 1,600.88%1.94M | 487.30%2.93M | 852.96%1.91M | -1.01%98K | 127.81%811K | 111.90%114K |
| -Change in prepaid assets | 10.39%-750K | -55.91%-1.03M | -189.38%-101K | 579.55%299K | 124.25%81K | -840.71%-837K | -194.64%-660K | 3,666.67%113K | -80.00%44K | -392.98%-334K |
| -Change in payables and accrued expense | 91.34%5.75M | 159.58%4.28M | 525.61%2.43M | -887.93%-4.83M | 195.19%3.87M | 512.50%3M | 107.29%1.65M | -38.35%-570K | 467.07%613K | 238.62%1.31M |
| -Change in other current liabilities | 34.12%1.02M | -150.41%-372K | 769.37%1.93M | -50.34%-436K | -208.70%-100K | 640.43%762K | 372.32%738K | 40.51%222K | -835.48%-290K | 2,966.67%92K |
| -Change in other working capital | ---- | ---- | 278.08%1.26M | 107.88%923K | -100.10%-1.91M | ---- | ---- | -4.86%333K | 32.93%444K | -633.85%-954K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -177.05%-69.1M | -279.97%-23.99M | -135.72%-14.93M | -217.12%-17.65M | -86.21%-12.53M | -20.01%-24.94M | -22.77%-6.31M | -36.00%-6.33M | -20.48%-5.57M | -5.75%-6.73M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -225.68M | 6.44M | 4.04M | -120.92M | -115.24M | 0 | 0 | 0 | 0 | 0 |
| Net PPE purchase and sale | ---218K | ---8K | ---191K | ---8K | ---11K | --0 | --0 | --0 | --0 | --0 |
| Net investment purchase and sale | ---225.46M | --6.45M | --4.23M | ---120.91M | ---115.23M | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---225.68M | --6.44M | --4.04M | ---120.92M | ---115.24M | --0 | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 18.33%213.03M | -53.82%57.06M | -94.23%2.28M | 795.36%152.75M | 938K | 1,177.46%180.02M | 123.56M | 11,420.76%39.4M | 6,149.65%17.06M | 0 |
| Net issuance payments of debt | --49.89M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | 8.05%148.96M | --0 | -122.18%-637K | ---- | ---- | 877.15%137.86M | --117.93M | 739.77%2.87M | ---- | ---- |
| Proceeds from stock option exercised by employees | -66.36%14.18M | 27.37%7.18M | -92.03%2.91M | --3.16M | --938K | --42.16M | --5.63M | --36.53M | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 18.33%213.03M | -53.82%57.06M | -94.23%2.28M | 795.36%152.75M | --938K | 1,177.46%180.02M | --123.56M | 11,420.76%39.4M | 6,149.65%17.06M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 1,062.04%169.68M | -7.67%48.41M | 194.42%57.02M | 444.16%42.85M | 1,062.04%169.68M | -31.46%14.6M | 165.49%52.44M | -19.52%19.37M | -72.82%7.87M | -31.46%14.6M |
| Current changes in cash | -152.72%-81.75M | -66.30%39.52M | -126.04%-8.61M | 23.34%14.18M | -1,785.17%-126.83M | 2,413.92%155.08M | 2,377.02%117.24M | 866.55%33.07M | 334.14%11.49M | -187.72%-6.73M |
| End cash Position | -48.18%87.93M | -48.18%87.93M | -7.67%48.41M | 194.42%57.02M | 444.16%42.85M | 1,062.04%169.68M | 1,062.04%169.68M | 165.49%52.44M | -19.52%19.37M | -72.82%7.87M |
| Free cash flow | -177.92%-69.31M | -280.09%-24M | -138.74%-15.12M | -217.27%-17.66M | -86.37%-12.54M | -19.94%-24.94M | -22.63%-6.31M | -36.00%-6.33M | -20.29%-5.57M | -5.75%-6.73M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.